e-learning
resources
Amsterdam 2011
Saturday, 24.09.2011
PG5 Asthma versus COPD: similarities and differences
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New bronchodilators and inhaled steroids
M. Cazzola (Rome, Italy)
Source:
Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences
Session:
PG5 Asthma versus COPD: similarities and differences
Session type:
Postgraduate Course
Number:
12
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Cazzola (Rome, Italy). New bronchodilators and inhaled steroids. Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
New bronchodilators
Source: Annual Congress 2012 - The promise of new drugs for treating asthma and COPD
Year: 2012
The effect of inhaled corticosteroids in combination with long-acting beta2-agonists in elite athletes with asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids
Source: Eur Respir J 2016; 48: 558-560
Year: 2016
Co-dispensing of inhaled corticosteroids and antibiotics
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012
Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening
Source: Eur Respir J 2001; 17: 1083-1088
Year: 2001
Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001
Novel long-acting bronchodilators
Source: Annual Congress 2009 - Emerging trends in the therapy of COPD
Year: 2009
Inhaled corticosteroid combined with long-acting bronchodilator versus long-acting bronchodilator alone for older patients with COPD
Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation
Year: 2015
Cough variant asthma treated with bronchodilators, without inhaled corticosteroids
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001
Inhaled steroids and COPD
Source: Eur Respir J 2008; 32: 523-524
Year: 2008
Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
Year: 2007
Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids
Source: Eur Respir J 2002; 19: 182-191
Year: 2002
Assessing regional airways responses to inhaled bronchodilators in asthmatics
Source: Annual Congress 2010 - Airways mechanics in different applications
Year: 2010
Timecourse of action of two inhaled corticosteroids, fluticasone propionate and budesonide
Source: Eur Respir J 2002; 20: Suppl. 38, 308s
Year: 2002
lnhaled long-acting beta-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults
Source: Eur Respir J 2005; 26: Suppl. 49, 124s
Year: 2005
Triple combination of montelukast or tiotropium and inhaled corticosteroids plus long-acting ß2-agonist in persistent asthma
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Short-acting bronchodilator and oral steroid use in asthma patients prescribed either concurrent beclometasone and salmeterol or combined salmeterol/fluticasone
Source: Eur Respir J 2004; 24: Suppl. 48, 309s
Year: 2004
Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept